Trial Site Detail
Drug: |
NN3201 |
|||
|---|---|---|---|---|
Trial: |
A Study of the C-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced And/or Metastatic Solid Tumors Known to Express C-Kit |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Arthur G. James Cancer Hospital300 W. 10th Ave. |
Principal Investigator: |
Gabriel Tinoco, MD |
|---|---|
Contact: |
Gabriel Tinoco, MD 410-294-9589 gabriel.tinoco@osumc.edu |
Activation Status of this Site: |
Active |
Notes about this Site: |
|
Arthur G. James Cancer Hospital Website: |
http://cancer.osu.edu/patientsandvisitors/Pages/index.aspx |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.